According to multiple recent market analyses, the global API market is experiencing steady growth. One comprehensive forecast ...

WENZHOU, ZHEJIANG PROVINCE, CHINA, January 19, 2026 /EINPresswire.com/ -- As the global pharmaceutical and healthcare ...

While the threat of U.S. import tariffs prompted a surge in drug production last year, that output is slated to slow across multiple geographies in 2026. | While the threat of U.S. import tariffs ...

The pharmaceutical industry operates under an uncompromising mandate: zero defects. Every tablet, capsule, vial, or syringe must meet exacting standards for dosage, purity, and sterility. This ...

As supply chain vulnerabilities intensify and competition accelerates, the cost of this underutilization could risk India's ...

HANGZHOU CITY, ZHEJIANG, CHINA, January 19, 2026 /EINPresswire.com/ -- With the development of the pharmaceutical and ...

For much of the past decade, drug shortages in the United States were treated as episodic disruptions. In 2024, that framing ...

The FDA began accepting requests Feb. 1 to participate in its PreCheck pilot program, an initiative aimed at streamlining regulatory review for new U.S.-based pharmaceutical manufacturing facilities.

The FDA laid out the qualifications a site would need to qualify for PreCheck on a webpage where companies can also submit requests to take part in the program. Companies are limited to one submission ...

PMMI research identifies top manufacturing hurdles including regulatory compliance, automation needs, and sustainability priorities ...

The CDMO Sector Holds a Core Position in the Pharmaceutical Industry As a major part of the outsourcing pharmaceutical service industry, CDMOs support pharmaceutical companies across the entire chain, ...

Biostin Pharma, Ahmedabad, is a WHO GMP-certified third-party pharma manufacturer committed to delivering high-quality pharmaceutical products to both Indian and international traders. With our ...